Last reviewed · How we verify
Venezuelan Equine Encephalitis DNA Vaccine
Venezuelan Equine Encephalitis DNA Vaccine is a Small molecule drug developed by PharmaJet, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Venezuelan Equine Encephalitis DNA Vaccine |
|---|---|
| Sponsor | PharmaJet, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection (PHASE1)
- Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Venezuelan Equine Encephalitis DNA Vaccine CI brief — competitive landscape report
- Venezuelan Equine Encephalitis DNA Vaccine updates RSS · CI watch RSS
- PharmaJet, Inc. portfolio CI
Frequently asked questions about Venezuelan Equine Encephalitis DNA Vaccine
What is Venezuelan Equine Encephalitis DNA Vaccine?
Venezuelan Equine Encephalitis DNA Vaccine is a Small molecule drug developed by PharmaJet, Inc..
Who makes Venezuelan Equine Encephalitis DNA Vaccine?
Venezuelan Equine Encephalitis DNA Vaccine is developed by PharmaJet, Inc. (see full PharmaJet, Inc. pipeline at /company/pharmajet-inc).
What development phase is Venezuelan Equine Encephalitis DNA Vaccine in?
Venezuelan Equine Encephalitis DNA Vaccine is in Phase 1.